GLAS CIK: 1848731

Glass House Brands Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
68.6
FY22:
38.9
FY23:
49.2
FY24:
66.1
FY25:
67.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
219
FY22:
312
FY23:
255
FY24:
244
FY25:
251
Total assets
Change from FY21 to FY25
millions USD
FY21:
288
FY22:
351
FY23:
304
FY24:
311
FY25:
319

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
55.2
FY22:
54.0
FY23:
87.4
FY24:
66.5
FY25:
38.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
50.4
FY22:
75.5
FY23:
71.2
FY24:
80.0
FY25:
106
(positive)
Change from FY21 to FY25
millions USD
FY21:
182
FY22:
169
FY23:
89.8
FY24:
116
FY25:
73.9
Total liabilities & equity
millions USD
FY21:
288
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR